drugset / Trial / NCT00651586

Safety and Efficacy Study of Gatifloxacin Compared With Ciprofloxacin in Patients With Acute Bacterial Corneal Ulcers

NCT00651586

Phase 2 Completed 129 enrolled Allergan
RandomizedParallel-groupDouble-blindTreatment

Summary

This study evaluates the safety and efficacy of gatifloxacin 0.3% ophthalmic solution compared with ciprofloxacin 0.3% ophthalmic solution in patients with acute bacterial corneal ulcers

Timeline

Start
2003-10
Primary completion
2005-04
Completion
2005-04

Publications

  • Background Prajna V, Vajpayee R, Trocme S, Davitt WF, III, Jensen H, Liu R, Safyan E. Safety and Efficacy of Gatifloxacin 0.3% as Compared With Ciprofloxacin 0.3% for the Treatment of Acute Bacterial Corneal Ulcers. Investigative Ophthalmology & Visual Science. 5-1-2006; 47(5):1916

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ciprofloxacin Small molecule 0.3 % Topical
Subject Gatifloxacin Small molecule 0.3 % Topical

Indications